Driving Medical Advancements Through AI: Newly Launched Institute to Catalyse Healthcare Innovation; MOU Signed to Strengthen Governance
The new Artificial Intelligence in Medicine Institute (AIMI) aims to spearhead cutting-edge AI research and seamlessly integrate it into a variety of medical fields. Its key priorities include championing safe and responsible AI use, highlighting patient safety and data privacy, promoting AI literacy among healthcare workers and the public, and collaborating with industry leaders to bring AI inventions to market.
A Memorandum of Understanding was also signed with the Coalition for Health AI (CHAI) to strengthen the pledge toward safe, ethical, and accountable use of AI in Singapore’s healthcare sector.
SINGAPORE – The SingHealth Duke-NUS Academic Medical Centre (AMC) officially introduced the Artificial Intelligence in Medicine Institute (AIMI) during the AI Health World Summit 2025’s opening ceremony, which was attended by a Guest-of-Honour from the Ministry of Digital Development and Information.
AIMI will unite SingHealth’s AI and data science expertise with Duke-NUS’s academic resources to advance research, education, and commercial opportunities in this domain.
By nurturing an ecosystem conducive to comprehensive AI research, education, and collaboration, the Institute bolsters healthcare professionals by incorporating sophisticated AI tools that enhance disease detection, guide clinical interventions, and improve patient satisfaction. As AI usage expands, providing the necessary support for clinical integration becomes vital.
Through the convergence of technical and clinical knowledge, strategic alliances, and dedicated funding, AIMI seeks to equip healthcare practitioners from various fields with the means to develop and adopt AI-based solutions in everyday practice.
To foster better AI understanding among healthcare workers and the general population, AIMI will roll out AI101, a core online training initiative that highlights the distinctive considerations and uses of AI in healthcare.
Recognising the importance of trustworthy and ethical AI adoption, AIMI will formulate guidelines, publish best practices, and propose policy frameworks to establish a stout governance structure for AI in healthcare.
A representative from the university noted, ‘AI holds immense potential to transform healthcare, but it must be implemented responsibly with patient interests at the core. AIMI integrates expertise from several disciplines—healthcare, engineering, and data science—turning data into urgent insights that enable swift, life-saving decisions at the bedside. In addition to the technology, we are dedicated to shaping the next generation of AI leaders through strategic alliances and education.’
Another significant event at the AI Health World Summit 2025 was the finalisation of a two-year MOU between SingHealth and CHAI, a U.S.-based non-profit focusing on AI best practices in healthcare. This marks CHAI’s inaugural international partnership, positioning Singapore as a prominent global centre for healthcare AI and promoting responsible AI implementation on a global scale.
With this alliance, both institutions will collaborate on AI guidelines, white papers, and policy recommendations, incorporating global leading practices to refine AI oversight within Singapore’s healthcare system. They also plan to offer educational programs that heighten AI awareness and ethical use among clinicians, developers, and the public.
Within the scope of this two-year agreement, SingHealth and CHAI will organise at least one Global Summit, convening experts, policymakers, and healthcare executives from around the world to share insights and experiences on AI governance and ethical considerations.
A university representative further commented, ‘As healthcare increasingly adopts AI, it becomes paramount for the technology sector and regulatory bodies to work closely to craft strong guidelines ensuring compliance with safety and governance criteria. Our ultimate goal is to design transparent, interpretable, and ethical AI systems that support clinicians in offering precise, personalised care while bringing about improved healthcare outcomes.’
Held every two years by the SingHealth Duke-NUS AMC in partnership with A*STAR, the AI Health World Summit 2025 is a pivotal occasion that gathers global authorities to explore the newest AI advances and applications in healthcare. The Summit includes sessions on technology implementation, clinical usage, data oversight, and ethical AI practices, featuring esteemed speakers from renowned institutions worldwide.
The SingHealth Duke-NUS Academic Medical Centre capitalises on the combined strengths of SingHealth and Duke-NUS Medical School to deliver exemplary patient services, while fostering progress through integrated research and learning initiatives. Duke-NUS Medical School also shapes future medical professionals and propels discoveries in biomedical science.
Annex A – About AIMI: The SingHealth Duke-NUS Artificial Intelligence in Medicine Institute (AIMI) is a collaborative institute that unites data science and AI resources across both healthcare and academic environments to promote teamwork, exploration, and innovation in healthcare AI. Its main goals include moving AI research from the lab to clinical settings, ensuring safe and responsible AI development, supporting AI-driven product development, and preparing the future healthcare workforce.
Annex B – About the MOU with CHAI: For a span of two years, SingHealth and CHAI will collaborate to further responsible AI in healthcare. This partnership aims to bolster Singapore’s status as an international AI hub by co-hosting a Global Summit, creating AI frameworks and policy proposals, and increasing awareness of ethical AI implementation in healthcare.
For additional details, please refer to the official websites of the SingHealth Duke-NUS AMC, SingHealth, and the Duke-NUS Medical School.
Source: https://finance.yahoo.com/news/advancing-artificial-intelligence-ai-medicine-020000468.html